fda glp-1 news november 2025 Beyond the Headlines: Warning Letters to Compounders FDA Drug Recalls and Warnings:

What were GLP-1s designed to do, and who are they for

Several syndromes originated from mitochondria-related mutations display ASD phenotype

These constraints have sparked new investigation of bioactive phytochemicals as complements to standard therapies, in an attempt to increase efficacy and reduce toxicity

The future of GLP-1RAs in anti-inflammatory therapy looks promising, with ongoing research aiming to optimize their therapeutic use, develop patient-specific treatment paradigms, and explore novel applications

Glickman adds

To experience a healthier gut and improved digestion during GLP-1 use, reach for Gut Responses cutting-edge GLP-1 Support formula